BrainBerry

BrainBerry is a research and development start-up that is leading the charge against neurological conditions. Our idea of digital healthcare came to the fore in 2016 when the company’s bootstrapping stage, leading to the idea of a therapy software highly focused on early onset symptoms of dementia. The development of the software tunnelled into the R&D process by end of 2016, leading us to start working on conducting a clinical trial with people to develop an evidence-based product aiming sincerely at treating dementia problems. Primarily focussed on researching the affects of neurofeedback and developing market-leading technology to help those suffering from dementia, We are currently working on two key products; COSMA Neurofeedback software and a Diagnostic EEG system which will be able to detect early signs of dementia.